関連する実験動画
Updated: Jul 14, 2026

10:32
Athymic Rat Model for Evaluation of Engineered Anterior Cruciate Ligament Grafts
Published on: March 26, 2015
バイオプロステスのミトラル構造不全の再手術:リスク評価
W R E Jamieson1, L H Burr, R T Miyagishima
1University of British Columbia, Vancouver, BC, Canada. wrej@interchange.ubc.ca
Circulation
|September 13, 2003
まとめ
ミトラバイオプロステスの故障再手術の死亡リスクは,ニューヨーク心臓協会 (NYHA) の低いクラスでの選択的処置によって減少します. 早期の患者評価により,生体義肢弁の劣化に対する早期の,低リスクの介入が可能になります.
科学分野:
- 心血管外科手術についてです.
- バイオメディカルエンジニアリング
- クリニカル・アウトカム・リサーチ 研究結果
背景:
- 構造弁の悪化は,バイオプロステティック弁の主要な合併症であり,しばしば再手術を必要とします.
- バイオプロステスのミトラバルブ機能不全の再手術は,重大な死亡リスクをもたらします.
- これらのリスクの評価と軽減は,患者管理において極めて重要です.
研究 の 目的:
- mitra bioprosthetic 機能不全に関連した死亡率を決定する.
- バイオプロステティックミトラ弁の機能不全による再手術後の死亡率に影響を与える危険因子を特定し,評価する.
主な方法:
- 1975年から1999年の間に実施された2,152件のミトラビオプロステス手術の遡及的分析.
- 構造弁の劣化のために481回の再操作が含まれています.
- 死亡率の予測要因を特定するための多変数回帰分析.
主要な成果:
- 再手術による全死亡率は7.1% (34例) であった.
- 選択的/緊急再手術 (6.0%) の死亡率は,緊急再手術 (17.8%) に比べて有意に低かった.
- 死亡率は時間とともに低下し,最も低い割合は1993年から2000年 (3.4%) に見られる.
- 予測要因には,インプラント/エクスプラントの年齢,緊急性,NYHAクラスが含まれていましたが,1993年から2000年にかけて,年齢のみが重要でした.
結論:
- 低〜中程度のNYHA機能クラスを持つ患者の選択的処置によって,ミトラバイオプロステスの再手術による死亡率を減らすことができます.
- 定期的な患者評価は,早期の介入を容易にし,再手術のリスクを下げる.
- 手術のタイミングと患者の選択を最適化することは,結果を改善する鍵です.
関連する概念動画
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

